GlaxoSmithKline Pharmaceuticals Limited Free Cash Flow Generation Index
GlaxoSmithKline Pharmaceuticals Limited free cash flow generation index. GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of Rs342.20 Million represents 1% of operating cash flow (Rs342.20 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Free cash flow generation index of GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025. Historical FCF Generation Index trend for GlaxoSmithKline Pharmaceuticals Limited across 21 annual periods. See GlaxoSmithKline Pharmaceuticals Limited financial flexibility index to measure the company's free cash flow as a share of total liabilities.
GlaxoSmithKline Pharmaceuticals Limited Free Cash Flow Generation Index by Year (2005–2025)
GlaxoSmithKline Pharmaceuticals Limited free cash flow generation index by year from 2005 to 2025. Year-by-year Free Cash Flow Generation Index for GlaxoSmithKline Pharmaceuticals Limited. For the full cash flow conversion analysis, see GLAXO cash generation efficiency.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.98x | Rs12.67 Billion | Rs12.90 Billion | Rs230.20 Million | ▲ +3.8% |
| 2024 | 0.95x | Rs5.51 Billion | Rs5.82 Billion | Rs312.21 Million | ▲ +4.1% |
| 2023 | 0.91x | Rs4.40 Billion | Rs4.84 Billion | Rs440.40 Million | ▼ -5.0% |
| 2022 | 0.96x | Rs7.76 Billion | Rs8.11 Billion | Rs346.41 Million | ▲ +3.7% |
| 2021 | 0.92x | Rs5.34 Billion | Rs5.78 Billion | Rs442.27 Million | ▲ +35.4% |
| 2020 | 0.68x | Rs3.35 Billion | Rs4.90 Billion | Rs1.56 Billion | ▲ +152.0% |
| 2019 | 0.27x | Rs1.08 Billion | Rs3.99 Billion | Rs2.91 Billion | ▲ +84.4% |
| 2018 | 0.15x | Rs694.12 Million | Rs4.73 Billion | Rs4.03 Billion | ▲ +150.6% |
| 2017 | -0.29x | Rs-684.33 Million | Rs2.36 Billion | Rs3.04 Billion | ▲ +56.7% |
| 2016 | -0.67x | Rs-931.30 Million | Rs1.39 Billion | Rs2.32 Billion | ▼ -229.4% |
| 2015 | 0.52x | Rs1.40 Billion | Rs2.70 Billion | Rs1.30 Billion | ▼ -34.8% |
| 2014 | 0.79x | Rs2.23 Billion | Rs2.81 Billion | Rs582.22 Million | ▼ -9.4% |
| 2013 | 0.88x | Rs2.75 Billion | Rs3.14 Billion | Rs390.76 Million | ▲ +0.1% |
| 2012 | 0.87x | Rs2.94 Billion | Rs3.36 Billion | Rs420.95 Million | ▼ -8.5% |
| 2011 | 0.96x | Rs4.58 Billion | Rs4.79 Billion | Rs213.94 Million | ▲ +1.6% |
| 2010 | 0.94x | Rs4.81 Billion | Rs5.12 Billion | Rs303.67 Million | ▲ +1.4% |
| 2009 | 0.93x | Rs3.06 Billion | Rs3.30 Billion | Rs238.79 Million | ▼ -2.6% |
| 2008 | 0.95x | Rs3.04 Billion | Rs3.19 Billion | Rs153.26 Million | ▲ +2.6% |
| 2007 | 0.93x | Rs2.40 Billion | Rs2.59 Billion | Rs186.23 Million | ▼ -0.5% |
| 2006 | 0.93x | Rs3.26 Billion | Rs3.49 Billion | Rs233.91 Million | ▼ -2.7% |
| 2005 | 0.96x | Rs2.20 Billion | Rs2.29 Billion | Rs93.72 Million | — |